Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. STKE, 10 April 2007
Vol. 2007, Issue 381, p. tw127
[DOI: 10.1126/stke.3812007tw127]

EDITORS' CHOICE

Lysophosphatidic acid Inhibition of IL-13 Signaling in Bronchial Epithelial Cells by LPA

John F. Foley

Science’s STKE, AAAS, Washington, DC 20005, USA

The cytokine interleukin-13 (IL-13), a Th2-associated cytokine, plays a role in the pathogenesis of bronchial asthma. IL-13 signals through its receptor, a heterodimer of IL-13 receptor {alpha}1 (IL-13R{alpha}1) and IL-4 receptor {alpha} (IL-4R{alpha}), to activate signal transducer and activator of transcription 6 (STAT6). Another receptor, IL-13R{alpha}2, with higher affinity for IL-13 than that of IL-13R{alpha}1, acts as a decoy receptor for IL-13, blocking its signaling. Phospholipid lysophosphatidic acid (LPA) has been detected in the lung and signals through G protein-coupled receptors to enhance production of epithelial chemokines. To investigate a role for LPA in airway modulation, Zhao et al. treated primary cultures of human bronchial epithelial cells (HBEpCs) with LPA for various time periods. Through real-time polymerase chain reaction and Western blotting analyses, the authors found that the abundance of mRNA and protein for IL-13R{alpha}2, but not IL-13R{alpha}1 or IL-4R{alpha}, were increased and that IL-13R{alpha}2 protein was secreted by the cells, with a peak production time after 6 hours of treatment. These effects were blocked if cells were pretreated with pertussis toxin, indicating that the effect of LPA on IL-13R{alpha}2 production was mediated by G proteins of the Gi family. Treatment of HBEpCs with LPA also blocked the ability of IL-13, but not IL-4, to activate STAT6. Studies with pharmacological inhibitors and small interfering RNA (siRNA) demonstrated that LPA stimulation of IL-13R{alpha}2 production was dependent on the activities of both c-Jun N-terminal kinase and phospholipase D. This study suggests that LPA functions to protect bronchial epithelium during airway inflammation in asthma.

Y. Zhao, D. He, J. Zhao, L. Wang, A. R. Leff, E. W. Spannhake, S. Georas, V. Natarajan, Lysophosphatidic acid induces interleukin-13 (IL-13) receptor {alpha}2 expression and inhibits IL-13 signaling in primary human bronchial epithelial cells. J. Biol. Chem. 282, 10172-10179 (2007). [Abstract] [Full Text]

Citation: J. F. Foley, Inhibition of IL-13 Signaling in Bronchial Epithelial Cells by LPA. Sci. STKE 2007, tw127 (2007).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882